Moreover, our previous findings had shown distinct changes in the methylation profile of inflammatory genes after different obesity treatments, with reduction in the IL-6 methylation level six months after RYGB [18]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.